Large-scale testing (Phase 3)Looking for participantsNCT06655883
What this trial is testing
Suvorexant (MK-4305) for the Treatment of Insomnia Disorder in Participants With Opioid Use Disorder (MK-4305-098)
Who this might be right for
Insomnia
Merck Sharp & Dohme LLC 300